Where does EXoCoBio Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), EXoCoBio Inc. ranks #28,725 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does EXoCoBio Inc. hold?

EXoCoBio Inc. holds 9 US utility patents granted between 2022 and 2023, spanning 7 technology areas.

What is EXoCoBio Inc.'s Innovation Score?

EXoCoBio Inc. has an Innovation Score of 48.8 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does EXoCoBio Inc. focus on?

EXoCoBio Inc.'s top technology area is A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations) with 9 patents, ranking #133 of 1,001 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is EXoCoBio Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for EXoCoBio Inc..

What does claim depth mean for EXoCoBio Inc.'s patents?

EXoCoBio Inc.'s patents average 19.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the EXoCoBio Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

EXoCoBio Inc.

USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, recorded in grant years 2022–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Exocobio ranks #28,725 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 7 technology areas.

#28,725
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.8/100): 19.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R28725 · Foreign Corporation #28,725 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 9 grants
MID-PACK #28,725/49,997
PHOTO-FINISH Eagantu
CPC-NARROW A61Q · 7 areas
INNOV-PAR 48.8/100
CLAIMS-RICH 19.1 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2023 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Eagantu Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Exocobio’s 48.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (16%) Velocity 20.0 pts (41%) Breadth 9.4 pts (19%) Claim depth 11.5 pts (24%)

Qualcomm Incorporated · highest

85
EXoCoBio · this assignee

49
3D Lighting… · lowest

7

What this shows Exocobio's Innovation Score is 48.8/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Exocobio?

Each dot is one of Exocobio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exocobio’s own 19.1 claims/patent is ABOVE the 17.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Exocobio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Exocobio's grants concentrate

EXoCoBio Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations). Peak complete grant year is 2022 (5 grants) versus a trough of 4 in 2023. By volume, Exocobio sits between Exicure, Inc. and Eagantu Ltd..

Exocobio's three-year grant acceleration

EXoCoBio Inc. shows 9 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Exicure

9
Exilant Private

9
Expliseat

9
Exterran Water So…

9
Eyesense

9
EYL

9
Ez-pro Texture

9
Eagantu

9
Exocobio ◀

9

What this shows EXoCoBio holds 9 patents at rank #28,667, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near EXoCoBio

By rank, the assignees closest to #28,667 in granted patent volume.

Leaders in A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations)

Other assignees with the most granted patents in EXoCoBio's primary technology class.

Exocobio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

EXoCoBio Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	5	55.6%
2023	4	44.4%

Which technologies does EXoCoBio Inc. patent most?

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 9

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

EXoCoBio Inc.'s patent record in context - here's where to go next.

EXoCoBio Inc.'s lead technology class is A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61Q
Ranked #28,725 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare EXoCoBio Inc. against Exicure, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.